Activation of natural cytotoxic activity and concomitant reduction of triglyceride content of murine spleen, treated with an antitumor antibiotic, ascofuranone.
Ascofuranone (AF) elevated natural cytotoxic activity of spleen when it was administered intraperitoneally to male mice. The elevation was observed both in low and high responder mice. AF-activated splenocytes lysed NK-resistant tumor cells, FM3A, P388 and sarcoma 180 cells as well as NK-sensitive YAC-1 cells. However, AF suppressed other lymphatic functions such as mitogenic responses and interleukin 2 production. Because AF did not activate splenic NK activity in vitro, the activation is assumed to be caused by a host-mediated process. One of the possibilities is modulation of the lipid metabolism of splenocytes. Thus, we examined splenic lipid contents and revealed that AF decreased splenic triglycerides without affecting other lipids. In contrast, the antibiotic significantly increased triglyceride in muscle.
D000818:Animals; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007111:Immunity, Cellular / Q000187:drug effects; D007694:Killer Cells, Natural / Q000276:immunology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D012717:Sesquiterpenes / Q000494:pharmacology*; D013154:Spleen / Q000187:drug effects* / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism*
D000960:Hypolipidemic Agents; D012717:Sesquiterpenes; D014280:Triglycerides; C006640:ascofuranone